Investigation on Synergistic Effect between Centralized Drug Quantity Purchase Policy and Medical Insurance Reimbursement System
返回论文页
|更新时间:2022-06-21
|
Investigation on Synergistic Effect between Centralized Drug Quantity Purchase Policy and Medical Insurance Reimbursement System
China PharmacyVol. 32, Issue 2, (2021)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2021,
扫 描 看 全 文
TAN Qingli, GAO Jiangyuan, LIN Daiheng. Investigation on Synergistic Effect between Centralized Drug Quantity Purchase Policy and Medical Insurance Reimbursement System. [J]. China Pharmacy 32(2).(2021)
DOI:
TAN Qingli, GAO Jiangyuan, LIN Daiheng. Investigation on Synergistic Effect between Centralized Drug Quantity Purchase Policy and Medical Insurance Reimbursement System. [J]. China Pharmacy 32(2).(2021)DOI:
Investigation on Synergistic Effect between Centralized Drug Quantity Purchase Policy and Medical Insurance Reimbursement System
OBJECTIVE:To investigate the synergistic effect and deficiencies between centralized drug quantity purchase policy and medical insurance reimbursement system ,and to provide feasible suggestion to further improve its synergistic effect. METHODS:The literature analysis method and policy evaluation method were adopted to expounds the direct and indirect synergistic effect between the current centralized drug quantity purchase policy and medical insurance reimbursement system in China,and analyze the existing problems so as to put forward the feasible suggestions. RESULTS & CONCLUSIONS :The centralized drug quantity purchase policy had a direct impact on the payment mode of medical insurance reimbursement system in technical level ,performance evaluation in effect level and process control in management level. The indirect synergy included : centralized drug quantity purchase policy could promote the adjustment of drug supply security system to adapt to the reform of medical insurance payment ;it could adjust the pharmaceutical market ,and affect the reform of medical insurance reimbursement system. The disadvantages were as follows :the varieties of selected drugs was still narrow ,and there was room for further improvement in purchasing scope and medical insurance fee reduction ;“one-size-fits-all”payment standard for unselected drug might weaken pharmaceutical companies ’enthusiasm for generic drug research and development. Therefore ,the next step is to significantly expand the variety and scope of procurement ,and appropriately liberalize the medical insurance payment restrictions for drugs with fewer varieties ;coordinate medical insurance reimbursement policies and procurement programs ,and improve the rationality and perfection of medical insurance payment ;guide the medical institutions to change the concept from “price-based medical treatment ”to“value-based medical treatment ”,take into account the interests of all parties in the market ,so as to form a comprehensive coordination adjustment mechanism of drug price and medical insurance reimbursement system.
Study on the synergistic effect and mechanism of curcumin combined with zerumbone on the biological behavior of non-small cell lung cancer cells
没食子酸与5种抗生素联用对铜绿假单胞菌的体外抑菌活性
右美托咪定不同给药途径对区域麻醉局麻药协同作用影响的研究进展
Related Author
LIU Jiaxin
ZHANG Yun
HUANG Huixian
LI Jianfen
YAO Zhixin
王春娟 左国营 王根春
王府
陈莹璐
Related Institution
TCM Pharmacy, Pharmacy Department, the First Affiliated Hospital of Guangzhou University of Chinese Medicine/Guangdong Clinical Research Academy of Chinese Medicine